Skip to main content

Summer Road LLC's Form 4 filing

Ocular Therapeutix, Inc (OCUL) · filed Dec 16, 2021

Accession no.
0001567619-21-022197
Filed
Dec 16, 2021
Trade date
Dec 14-15, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions. Open-market purchases total $282.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Summer Road LLCCIK 000160487310% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 14, 2021Common Stock, $0.0001 par value per sharePPurchaseAcquired+29,490$6.41F4+$189,030.95,749,761Indirect
Dec 15, 2021Common Stock, $0.0001 par value per sharePPurchaseAcquired+15,000$6.22F5+$93,3005,764,761Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

Represents the weighted average set forth in this line item. On December 14, 2021, the Reporting Person acquired 29,490 shares of Common Stock at a weighted average price of $ 6.4149 (ranging from a low of $6.26 and a high of $6.66). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents the weighted average set forth in this line item. On December 15, 2021, the Reporting Person acquired 15,000 shares of Common Stock at a weighted average price of $ 6.2164 (ranging from a low of $6.1714 and a high of $6.67). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)